Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro

British Journal of Cancer

Volumn 76, Issue 8, 1997, Pages 1017-1020

  Colston, K W ^a   James, S Y ^a   Ofori Kuragu, E A ^a   Binderup, L ^b   Grant, A G ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LEO PHARMA A S   (Denmark)

Author keywords

Growth inhibition; Pancreatic carcinoma; Vitamin D

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; SEOCALCITOL; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYPERCALCEMIA; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; TUMOR XENOGRAFT;

EID: 0030828301     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.501     Document Type: Article

References (25)

1. 3 inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcaemia. Endocrinology 129: 832-837
2. Andren-Sandberg A and Backman PL (1990) Sex hormones and pancreatic cancer. Baillière's Clin Gastroenterol 4: 941-952
3. Bakkevold KE, Petersen A, Arnesjo B and Espehaug B (1990) Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater. Br J Surg 77: 725-730
4. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of dye binding. Anal Biochem 72 248-254
5. 3 analogues with potent effects on cell growth regulation and immune responses: structure activity studies. In Vitamin D: Gene Regulation, Structure-Function Analysis and Clinical Application, Norman AW, Boullion R and Thomassel M. (eds). pp. 478-485. Walter de Gruyter: Berlin
6. Bold RJ, Ishizuka JI, Townsend CM and Thompson JC (1996) All-trans retinoic acid inhibits growth of human pancreatic cell lines. Pancreas 12: 189-195
7. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108: 1083-1086
8. 3 binding in oestrogen-responsive rat breast tumour. Endocrinology 119: 397-403
9. Colston KW, Chander SK, Mackay AG and Coombes RC (1992a) Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 44: 673-702
10. Colston KW, Mackay AG, James SY, Binderup L, Chander S and Coombes (1992b) EB 1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 44: 2273-2280
11. 3 receptor. Cancer Res 44: 2103-2109
12. 3 metabolites. Cancer Res 43: 4443-4447
13. Grant AG, Duke D and Hermon-Taylor J (1979). Establishment and characterization of primary human pancreatic carcinoma in continuous cell culture and in nude mice. Br J Cancer 39: 143-151
14. Grant AG, Flomen RM, Tizard ML and Grant DAW (1992) Differential screening of a human pancreatic adenocarcinoma 1g11 expression library has identified increased transcription of elongation factor EF-1a in tumour cells. Int J Cancer 51: 740-745
15. Grant AG, Binderup L and Colston KW (1993) Vitamin D receptors and antiproliferative effects of vitamin D derivatives on pancreatic adenocarcinoma cells. J Endocrinol 137 (suppl): 40
16. James SY, Mackay AG, Binderup L and Colston KW (1994) Effects of a new synthetic vitamin D analogue, EB 1089, on the oestrogen-responsive growth of human breast cancer cells. J Endocrinol 141: 555-563
17. James SY, Mackay AG and Colston KW (1995) Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J Molec Endocrinology 14: 391-394
18. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB (1992) Wild-type p53 is a cell cycle determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495
19. Mathiasen IS, Colston KW and Binderup L (1993) EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Molec Biol 46: 365-371
20. McGuire WL and De La Garza M (1973) Improved sensitivity in the measurement of estrogen receptors in human breast cancer. J Clin Endocrinol Metab 37: 986-989
21. Poston GJ, Townsend CM Jr, Rajaraman S, Thompson JC and Singh P (1990) Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice. Pancreas 5: 152-157
22. Taylor OM, Benson EA and McMahon MJ (1993) Clinical trial of Tamoxifen in patients with irresectable pancreatic adenocarcinoma. Br J Surg 80: 384-386
23. Wong A and Chan A (1993) Survival benefit of Tamoxifen therapy in adenocarcinoma of pancreas. Cancer 71: 2200-2203
24. Wosikowski K, Kung W, Hasmann M, Loser R and Eppenberger U (1993) Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells. Int J Cancer 53: 290-297
25. Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K and Knabbe C (1996) Growth inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer 73: 1341-1346